FormWeb • pitavastatin

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

pitavastatin magnesium, pitavastatin sodium

pitavastatin

Restricted HMG CoA Reductase Inhibitor Formulary
Therapeutic Interchange

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Livalo, Nikita, Zypitamag	TABLET, ORAL	1 mg, 2 mg, 4 mg

VIEW MORE HMG-CoA Reductase Inhibitors

Comments:

Livalo and Zypitamad is approved for sample use in HH Endocrinology and Diabetes Clinics.

Livalo, Nikita, and Zypitamag are judged to be interchangeable, an automatic interchange of these 3 drugs has been approved and the product that is the most economical at any given time will be purchased.

Reviewed: February 24, 2010, September 25, 2012, and 24 July 2018 (Nikita and Zypitamag)

Last updated: Jan. 17, 2023

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.